Maternal Prenatal Cannabis Use and Child Autism Spectrum Disorder.

ABSTRACT:

Importance

Despite an increase in maternal prenatal cannabis use and associations with adverse neonatal outcomes, research on child neurodevelopmental outcomes is limited.

Objective

To evaluate the association between maternal cannabis use in early pregnancy and child autism spectrum disorder (ASD).

Design, setting, and participants

This population-based retrospective birth cohort study included children born between 2011 and 2019 to pregnant Kaiser Permanente Northern California members screened for prenatal cannabis use during pregnancy. Statistical analysis was conducted February 2023 to March 2024.

Exposures

Maternal prenatal cannabis use was assessed at entrance to prenatal care (approximately 8- to 10-weeks' gestation) via self-report and/or positive urin

SUBMITTER: Avalos LA 

PROVIDER: S-EPMC11581557 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature